PTX3 and breast cancer: The modulation of PTX3 expression in these cells by shRNA-mediated silencing or lentiviral-driven overexpression shows that progressive epigenetic silencing of PTX3 facilitates the proliferative potential of BC cells and progressively favors an increased metabolic fitness of cancer cells towards a more glycolytic/aggressive phenotype.